News Room
Technophage was recognized with ‘PME líder 2024’ distinction by IAPMEI
We are thrilled to announce that Technophage has once again been recognized by IAPMEI, I.P. – Agência para a Competitividade e Inovação (Agency for...
Technophage named one of seven biotech companies to know in Portugal
Technophage has been featured in the recent article "The 7 Biotech Companies in Portugal You Should Know About in 2024" by Labiotech! This...
Technophage attended AMR Innovation Mission 2024 in the United Kingdom
We are thrilled to announce that Technophage was selected by Innovate UK as one of the 19 most promising solutions globally in the fight against...
Pipeline
Invest in our products
GMP manufacturing
Learn more about GMP manufacturing
Technophage
Who we are, What we do
Therapeutic
areas
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology